It boosts the immune system, and laboratory tests have even shown
its effectiveness against cancer cells.
Not exact matches
It showed
effectiveness against liver
cancer in a phase II clinical trial and will move into a phase III trial later this year, David Kirn, an oncologist and the company's president and chief executive officer, said at a recent meeting of the American Society for Gene &
Cell Therapy in Washington, D.C..
The purpose of this study is to compare the
effectiveness of daratumumab in combination with atezolizumab
against atezolizumab alone in patients who have advanced non-small
cell lung
cancer (NSCLC) that has previously been treated.